BACKGROUND: Colorectal carcinoma is the second most common cause of cancer death with African Americans having lower survival compared with White Americans. The purpose of this study was to investigate the effect of demographics, clinical factors, and socioeconomic status (SES) on racial disparities in colorectal cancer survival in the Detroit Metropolitan Area. METHODS: The study population included 9078 individuals with primary invasive colorectal cancer identified between 1988 and 1992 through the Surveillance, Epidemiology, and End Results (SEER) program. Demographics, clinical information, and survival were obtained through SEER. SES was categorized using occupation, educational level, and poverty status at the census tract level. Kaplan-Meier survival curves and Cox proportional hazards regression were used to compare overall survival by race. RESULTS: African Americans were more likely to be diagnosed with stage IV disease (P < .001), and to reside within poor census tracts (P < .001) compared with White Americans. Unadjusted analysis showed that African Americans had a significantly higher risk of death compared with their White American counterparts (hazards ratio [HR], 1.13; 95% confidence interval [CI], 1.07-1.20). After adjusting for age, marital status, sex, SES group, TNM stage, and treatment, race was no longer significantly associated with overall survival (HR, 1.00; 95% CI, 0.92-1.09). Similar results were seen with colorectal cancer-specific survival. CONCLUSIONS: Racial disparities in colorectal cancer survival dissipate after adjusting for other demographic and clinical factors. These results can potentially affect medical guidelines regarding screening and treatment, and possibly influence public health policies that can have a positive impact on equalizing racial differences in access to care.
BACKGROUND:Colorectal carcinoma is the second most common cause of cancer death with African Americans having lower survival compared with White Americans. The purpose of this study was to investigate the effect of demographics, clinical factors, and socioeconomic status (SES) on racial disparities in colorectal cancer survival in the Detroit Metropolitan Area. METHODS: The study population included 9078 individuals with primary invasive colorectal cancer identified between 1988 and 1992 through the Surveillance, Epidemiology, and End Results (SEER) program. Demographics, clinical information, and survival were obtained through SEER. SES was categorized using occupation, educational level, and poverty status at the census tract level. Kaplan-Meier survival curves and Cox proportional hazards regression were used to compare overall survival by race. RESULTS: African Americans were more likely to be diagnosed with stage IV disease (P < .001), and to reside within poor census tracts (P < .001) compared with White Americans. Unadjusted analysis showed that African Americans had a significantly higher risk of death compared with their White American counterparts (hazards ratio [HR], 1.13; 95% confidence interval [CI], 1.07-1.20). After adjusting for age, marital status, sex, SES group, TNM stage, and treatment, race was no longer significantly associated with overall survival (HR, 1.00; 95% CI, 0.92-1.09). Similar results were seen with colorectal cancer-specific survival. CONCLUSIONS: Racial disparities in colorectal cancer survival dissipate after adjusting for other demographic and clinical factors. These results can potentially affect medical guidelines regarding screening and treatment, and possibly influence public health policies that can have a positive impact on equalizing racial differences in access to care.
Authors: N Krieger; C Quesenberry; T Peng; P Horn-Ross; S Stewart; S Brown; K Swallen; T Guillermo; D Suh; L Alvarez-Martinez; F Ward Journal: Cancer Causes Control Date: 1999-12 Impact factor: 2.506
Authors: Arnold L Potosky; Linda C Harlan; Richard S Kaplan; Karen A Johnson; Charles F Lynch Journal: J Clin Oncol Date: 2002-03-01 Impact factor: 44.544
Authors: Dominik D Alexander; John Waterbor; Timothy Hughes; Ellen Funkhouser; William Grizzle; Upender Manne Journal: Cancer Biomark Date: 2007 Impact factor: 4.388
Authors: Amanda I Phipps; John Scoggins; Mary Anne Rossing; Christopher I Li; Polly A Newcomb Journal: Am J Public Health Date: 2012-01-19 Impact factor: 9.308
Authors: Kristin Wallace; David N Lewin; Shaoli Sun; Clayton M Spiceland; Don C Rockey; Alexander V Alekseyenko; Jennifer D Wu; John A Baron; Anthony J Alberg; Elizabeth G Hill Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-05-16 Impact factor: 4.254
Authors: Felicity W K Harper; Andrea Nevedal; Susan Eggly; Carie Francis; Kendra Schwartz; Terrance L Albrecht Journal: Transl Behav Med Date: 2013-03 Impact factor: 3.046
Authors: Kevin M Gorey; Isaac N Luginaah; Eric J Holowaty; Guangyong Zou; Caroline Hamm; Emma Bartfay; Sindu M Kanjeekal; Madhan K Balagurusamy; Sundus Haji-Jama; Frances C Wright Journal: BMC Public Health Date: 2012-10-24 Impact factor: 3.295